Clinical trial
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node…
NCT00004196 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00004196 |
|---|---|
| Title | Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis |
| Official title | A Multicenter Trial of Adjuvant Interferon Alfa-2b for Melanoma Patients With Early Lymph Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological, Drug, Procedure |
| Interventions | recombinant interferon alfa, lymphangiography, Observation |
| Enrollment | 3,000 |
| Start date | Oct 1, 1999 |
| Primary completion | Oct 1, 2004 |
| Completion | Nov 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: